| Financial Year |
March 31 2021 |
| Monetary Funds |
57,425,847.71 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,418,119.42 |
| Accounts Receivable |
407,124,783.64 |
| Advances to Suppliers |
92,191,007.69 |
| Other Receivables |
89,482,412.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
497,356.36 |
| Dividend Receivable |
-- |
| Inventories |
251,241,448.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
747,319,172.75 |
| Total Current Assets |
1,647,202,792.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
200,000,956.79 |
| Investment Properties |
-- |
| Fixed Assetes |
1,858,965,738.32 |
| Under-construction Projects |
6,635,994,770.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
48,121,984.67 |
| R&D expenses |
-- |
| Goodwill |
347,222,087.88 |
| Long-Term Deferred and Prepaid Expenses |
62,215,545.81 |
| Deferred Income Tax Assets |
671,696,445.67 |
| Other Non-Current Assets |
1,954,843,480.51 |
| Sub-Total of Non-Current Assets |
11,779,061,010.55 |
| Total Assets |
13,426,263,802.78 |
| Short-Term Loans |
1,862,215,201.73 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,802,132,942.25 |
| Accounts Received In Advance |
17,354,297.44 |
| Employee Compensation Payable |
77,706,838.52 |
| Taxes Payable |
4,479,089.87 |
| Interest Payable |
1,142,612,469.03 |
| Dividend Payable |
-- |
| Other payables |
2,613,755,798.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,181,502,616.83 |
| Other Current Liabilities |
1,444,492.79 |
| Sub-Total of Current Liabilities |
10,571,906,100.97 |
| Long-term Loans |
1,421,296,137.66 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
297,613,153.42 |
| Special Payable |
-- |
| Estimatied Liabilities |
82,390,919.06 |
| Deferred Income Tax Liabilities |
98,525,594.09 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,940,031,910.68 |
| Total Liabilities |
12,511,938,011.65 |
| Paid-In Capital(Or Share Stock) |
1,087,191,760.00 |
| Capital Surplus |
4,759,033,510.13 |
| Surplus Reserve |
22,605,403.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-4,960,629,528.21 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
914,325,791.13 |
| Owner's Equity（Stockholder's Equity） |
914,325,791.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,426,263,802.78 |
